Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients

por Araldi, Rodrigo Pinheiro, Prezoto, Benedito Carlos, Gonzaga, Vivian, Policiquio, Bruna, Mendes, Thais Biude, D’Amélio, Fernanda, Vigerelli, Hugo, Viana, Mariana, Valverde, Cristiane Wenceslau, Pagani, Eduardo, Kerkis, Irina
Publicado 2022